SELTA SQUARE
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $6.4M
Investors
- 5
About SELTA SQUARE
Founded in 2021, and based in Seoul, South Korea, SELTA SQUARE operates as a pharmacovigilance company that uses AI-based technologies to provide drugs efficiency monitoring services. Through its platform users can get information of the efficiency of new pharmaceutical products. Financial terms of the deal were not disclosed.
Who invested in SELTA SQUARE
5 investors across 2 rounds
See all investors in SELTA SQUARE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SELTA SQUARE
Who invested in SELTA SQUARE?
SELTA SQUARE has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SELTA SQUARE raised?
SELTA SQUARE has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SELTA SQUARE last raise money?
SELTA SQUARE's most recent round on record is a Series A, in Jan 2025.
What does SELTA SQUARE do?
Founded in 2021, and based in Seoul, South Korea, SELTA SQUARE operates as a pharmacovigilance company that uses AI-based technologies to provide drugs efficiency monitoring services.
Where is SELTA SQUARE headquartered?
SELTA SQUARE is headquartered in Seoul, South Korea.
Which VCs invest in companies like SELTA SQUARE?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at SELTA SQUARE's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like SELTA SQUARE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.